We are live on !
Find out more
NF Trinity Capital Portfolio holdings
AUM
$626M
Turnover
24%
1-Year Est. Return
3.16%
This Fund
S&P 500
This Quarter Est. Return
+22.81%
1 Year Est. Return
+3.16%
3 Year Est. Return
+49.61%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$626M
AUM Growth
+$10.4M
(+1.7%)
Cap. Flow
-$107M
Cap. Flow % of AUM
Cap. Flow %
-17.14%
Top 10 Holdings %
Top 10 Hldgs %
69.81%
Holding
50
New
1
Increased
5
Reduced
12
Closed
11
Avg Time Held
2.1
years
Top 10 Avg Time Held
1.9
years
Top 20 Avg Time Held
1.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$5.16M |
| 2 |
Booking.com
BKNG
|
+$3.14M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$2.49M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$2.19M |
| 5 |
Amazon
AMZN
|
+$1.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$14M |
| 2 |
JD.com
JD
|
+$10.9M |
| 3 |
Bank of America
BAC
|
+$9.7M |
| 4 |
Meta Platforms (Facebook)
META
|
+$9.6M |
| 5 |
FNSR
Finisar Corp
FNSR
|
+$8.45M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 34.18% |
| 2 | Consumer Discretionary | 28.25% |
| 3 | Financials | 12.43% |
| 4 | Healthcare | 9.71% |
| 5 | Technology | 9.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Gilead Sciences
GILD
$190B
| $5.65M | 0.9% |
86,959
| – | – |
2015 Q4
13 quarters
|
|
27
TAL Education Group
TAL
$6.6B
| $5.22M | 0.83% |
144,791
-84,000
| -37% | -$2.72M |
2018 Q2
3 quarters
|
|
28
iShares Biotechnology ETF
IBB
$10.6B
| $4.83M | 0.77% |
43,200
| – | – |
2015 Q4
13 quarters
|
|
29
Deutsche Bank
DB
$59.4B
| $4.33M | 0.69% |
533,225
| – | – |
2018 Q1
4 quarters
|
|
30
DELISTED
Sage Therapeutics
SAGE
| $3.07M | 0.49% |
19,313
-13,193
| -41% | -$1.91M |
2018 Q2
3 quarters
|
|
|
31
Booking.com
BKNG
$122B
| $3.07M | 0.49% |
+44,000
| New | +$3.14M |
2019 Q1
0 quarters
|
|
32
Viatris
VTRS
$21B
| $2.83M | 0.45% |
100,000
| – | – |
2016 Q1
12 quarters
|
|
33
Incyte
INCY
$23B
| $2.67M | 0.43% |
31,000
| – | – |
2017 Q4
5 quarters
|
|
34
SLB Ltd
SLB
$72.8B
| $2.42M | 0.39% |
55,500
| – | – |
2015 Q4
13 quarters
|
|
|
MNK
35
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $2.22M | 0.35% |
102,000
| – | – |
2017 Q3
6 quarters
|
|
36
Iovance Biotherapeutics
IOVA
$6.44B
| $2.17M | 0.35% |
228,442
| – | – |
2018 Q2
3 quarters
|
|
37
Viking Therapeutics
VKTX
$3.19B
| $1.39M | 0.22% |
140,000
| – | – |
2018 Q4
1 quarter
|
|
38
Fluent
FLNT
$85.7M
| $1.1M | 0.18% |
32,467
| – | – |
2015 Q4
13 quarters
|
|
|
ARAV
39
DELISTED
Aravive, Inc. Common Stock
ARAV
| $287K | 0.05% |
40,816
| – | – |
2016 Q3
10 quarters
|
|
40
DELISTED
Apellis Pharmaceuticals
APLS
| – | – |
-357,142
| Closed | -$4.71M | – |
|
41
Salesforce
CRM
$200B
| – | – |
-28,088
| Closed | -$3.85M | – |
|
42
Goldman Sachs
GS
$255B
| – | – |
-3,700
| Closed | -$618K | – |
|
43
Himax Technologies
HIMX
$2.09B
| – | – |
-470,000
| Closed | -$1.61M | – |
|
44
Mercado Libre
MELI
$93.3B
| – | – |
-21,189
| Closed | -$6.2M | – |
|
45
Philip Morris
PM
$313B
| – | – |
-63,000
| Closed | -$4.21M | – |
|
46
Teva Pharmaceutical Industries Limited
TEVA
$48.2B
| – | – |
-53,000
| Closed | -$817K | – |
|
47
Vipshop
VIPS
$6.09B
| – | – |
-52,644
| Closed | -$287K | – |
|
|
XLRN
48
DELISTED
Acceleron Pharma
XLRN
| – | – |
-14,369
| Closed | -$626K | – |
|
|
CELG
49
DELISTED
Celgene Corp
CELG
| – | – |
-107,491
| Closed | -$6.89M | – |
|
|
FNSR
50
DELISTED
Finisar Corp
FNSR
| – | – |
-391,000
| Closed | -$8.45M | – |
|
Similar funds
DSI
SCA
SHCM
IAS
NF Trinity Capital's Q1 2019 Portfolio in Review
As of Q1 2019, NF Trinity Capital held 50 positions worth $626M, up 1.7% from $615M the previous quarter. Its ten largest holdings account for 70% of the portfolio.
NF Trinity Capital withdrew a net $107M in Q1 2019, closing 11 positions and reducing 12 holdings. Its most notable exit was Finisar Corp, an estimated $8.45M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 34% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, NF Trinity Capital opened a new position in Booking.com worth $3.07M.
- NF Trinity Capital's largest Q1 2019 buy was Booking.com: 44,000 shares worth $3.07M.
- NF Trinity Capital added most to Walt Disney in Q1 2019, an estimated $5.16M increase.
- NF Trinity Capital's biggest Q1 2019 reduction was Alibaba, cutting an estimated $14M.
- NF Trinity Capital fully exited Finisar Corp in Q1 2019, selling an estimated $8.45M.
- NF Trinity Capital's ten largest holdings make up 70% of its $626M portfolio in Q1 2019.
- NF Trinity Capital opened 1 new position and closed 11 in Q1 2019.
- NF Trinity Capital's portfolio value rose 1.7% quarter-over-quarter to $626M.
Based on NF Trinity Capital's 13F filing for Q1 2019, filed 10 May 2019.